A major advance in cancer study is occurring with the use of VHH fragments to re-engage mutated p53. This vital cancer inhibitor protein is frequently lost in several forms of malignancies, leading uncontrolled cell https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research